Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
API
1801
Agora
API
$344M
| $2.86M | ﹤0.01% |
789,000
-147,666
| -16% | -$565K |
|
1802
1-800-Flowers.com
FLWS
$269M
| $2.85M | ﹤0.01% |
248,300
-202,900
| -45% | -$2.08M |
|
1803
Lloyds Banking Group
LYG
$90.8B
| $2.85M | ﹤0.01% |
1,230,700
+598,100
| +95% | +$1.45M |
|
|
ESGR
1804
DELISTED
Enstar Group
ESGR
| $2.85M | ﹤0.01% |
12,300
-1,100
| -8% | -$260K |
|
|
VIA
1805
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $2.83M | ﹤0.01% |
154,101
-7,229
| -4% | -$204K |
|
1806
iShares MSCI Japan ETF
EWJ
$22B
| $2.83M | ﹤0.01% |
+48,200
| New | +$2.74M |
|
|
IAS
1807
DELISTED
Integral Ad Science
IAS
| $2.83M | ﹤0.01% |
198,100
-11,980
| -6% | -$135K |
|
1808
RLJ Lodging Trust
RLJ
$1.87B
| $2.83M | ﹤0.01% |
266,600
-167,132
| -39% | -$1.88M |
|
1809
TriMas Corp
TRS
$1.45B
| $2.82M | ﹤0.01% |
101,355
-19,915
| -16% | -$584K |
|
|
TBI
1810
Trueblue
TBI
$229M
| $2.82M | ﹤0.01% |
158,421
+104,121
| +192% | +$1.95M |
|
1811
BWX Technologies
BWXT
$15.9B
| $2.81M | ﹤0.01% |
44,600
+25,400
| +132% | +$1.53M |
|
1812
Mitek Systems
MITK
$767M
| $2.81M | ﹤0.01% |
292,500
-39,500
| -12% | -$379K |
|
|
NXGN
1813
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.8M | ﹤0.01% |
160,976
-57,700
| -26% | -$1.04M |
|
1814
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.97B
| $2.8M | ﹤0.01% |
119,288
-42,615
| -26% | -$1.01M |
|
|
SOVO
1815
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $2.8M | ﹤0.01% |
167,900
+8,800
| +6% | +$124K |
|
1816
iShares MSCI USA Momentum Factor ETF
MTUM
$25.6B
| $2.79M | ﹤0.01% |
+20,100
| New | +$2.84M |
|
1817
Certara
CERT
$1.27B
| $2.79M | ﹤0.01% |
115,900
+21,000
| +22% | +$415K |
|
1818
Valhi
VHI
$380M
| $2.79M | ﹤0.01% |
160,117
+12,500
| +8% | +$282K |
|
|
GOEV
1819
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $2.78M | ﹤0.01% |
+9,259
| New | +$3.92M |
|
1820
i3 Verticals
IIIV
$418M
| $2.78M | ﹤0.01% |
113,300
+89,200
| +370% | +$2.34M |
|
1821
G-III Apparel Group
GIII
$1.54B
| $2.78M | ﹤0.01% |
+178,503
| New | +$2.8M |
|
1822
Element Solutions
ESI
$9.18B
| $2.77M | ﹤0.01% |
143,600
-383,900
| -73% | -$7.57M |
|
1823
Recursion Pharmaceuticals
RXRX
$1.69B
| $2.77M | ﹤0.01% |
415,561
+221,661
| +114% | +$1.76M |
|
1824
State Street SPDR S&P Homebuilders ETF
XHB
$1.49B
| $2.77M | ﹤0.01% |
+40,900
| New | +$2.73M |
|
|
AAN
1825
DELISTED
The Aaron's Company Inc
AAN
| $2.77M | ﹤0.01% |
286,400
+236,900
| +479% | +$3.04M |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.